leukemia is not so much the sheer volume of information, but the sense that these three streams of thought are gradually finding certain common mechanistic ground wherein genetics, viruses, and hormones may all play discrete parts in the pathogenesis of these complex disorders. It is toward this goal that editors Gale and Golde vigorously encourage future research directions in hope of achieving a broader understanding of these and other cancers.
The second half of this symposium deals with more clinical issues and problems in the treatment of leukemias. A chapter on pharmacology discusses the molecular mechanisms of acquired malignant cell drug resistance to specific agents. It includes Joseph Bertino's work with methotrexate resistance and the experimental antifolate trimetrexate, as well as several clinical trials of varying drug regimens of cytosine arabinoside for use as a CNS prophylactic. The final chapter on therapy provides an excellent summary of the most up-to-date drug regimens, therapeutic tactics, and prognosis in childhood and adult ALL, AML, CML, CLL, and hairy-cell leukemia. Particular emphasis is placed on the encouraging advances made in allogeneic bone marrow transplants and experimental work with autologous marrow treated in vitro with monoclonal antibodies and complement. As exciting as these successes have been, Gale appropriately reminds the reader of how limited the patient population with histocompatible donors is and advocates using our recent fundamental advances in the understanding of the basic biology of leukemias to lead, it is hoped, to the development of more effective and less toxic approaches to the treatment of these diseases.
This well-balanced symposium avoids the pitfalls to which many volumes of this size succumb, by neither losing focus of the clinical issues nor attempting to address too large a scientific field. It provides a wide representation of topics in sufficient depth to be of interest to the molecular biologist as well as the student of research oncology and is more than just academic reading for the medical oncologist. The study of virology remains one of the frontiers of medicine. Viruses have been implicated in a wide range of disease processes in all fields of medicine, from trivial upper respiratory tract infections to malignancy. It is a sign of our ignorance, however, that a viral etiology is often postulated either as a diagnosis of exclusion-as in cases of gastroenteritis or upper respiratory tract infections, or as a potential cause of a poorly understood disease-as in the case of multiple sclerosis or Type I diabetes.
Until recently, diagnostic methods have not been readily available, and there was little in the way of antiviral therapy to offer even if a specific diagnosis could be made. These factors further diminished interest in virology among clinicians.
All of this is changing rapidly. Viruses have been implicated in an ever-growing number of disease processes, including AIDS. Effective and rapid assays using immunologic techniques have been mass marketed, and new antiviral agents, such as acyclovir, have removed viruses from the category of untreatable pathogens.
The book is intended as a basic reference for students and clinicians, and covers a comprehensive range of topics. Beginning with sections on viral structure and function, the editors have assembled chapters which discuss the epidemiology and pathology of viral infection, immunization, viruses and cancer, new and emerging viral diseases, antiviral therapy, and diagnostic methods, in addition to a number of chapters which catalogue the many viral diseases.
The book is too short to be an authoritative text on such a broad topic; therefore, it is impossible not to mention areas where a more detailed coverage might be indicated. For example, the section on AIDS, which is perhaps the most significant and intriguing recently discovered disease process, merits less than a page of discussion in the chapter on new and emerging viral diseases. However, scattered shortcomings should not detract from the generally excellent job done by the editors in assembling a book which makes virology so readily accessible. How aggressively to treat newborns with severe birth defects is a vexing question. Robert Weir has done a thorough and admirably dispassionate job dissecting out and examining the critical issues entangled in this problem. The author wastes no time pointing out that infanticide, whether active or passive, is nothing new. It was practiced in most ancient cultures and has remained prevalent into the twentieth century. In the U.S. today, the neonatal intensive care unit (NICU) is almost always the setting for deciding whether anomalous newborns should be allowed to die. Here, parents and medical teams usually have been free to choose treatment or nontreatment for these infants with little outside interference. However, some recent cases have received intense public scrutiny, and the federal government has taken a new interest in applying statutes, outlawing discrimination against the handicapped to defective infants, in order to compel medical treatment for birth defects which might be lethal if left untreated.
At the core of this problem is the question of where the best interests of severely anomalous infants lie: is death preferable to a seriously handicapped existence which may be punctuated by repeated and painful corrective procedures? The range of opinion is as wide within the medical profession as elsewhere. Since 1970 Duff and Campbell have recognized selective nontreatment for some birth defects as reasonable, citing severe spina bifida cystica as their prime example. On the other hand, Surgeon General Everett Koop maintains that nontreatment in non-terminal cases is wrong; he cites the sanctity of all human life as well as the fact that sometimes treatment is withheld primarily to spare parents the burden of raising a handicapped child. Somewhere in between is Norman Fost, who agrees that it is in the best interests of some anomalous infants to be allowed to die, but who insists that the interests of parents and society are essentially irrelevant in deciding not to treat them. He also notes an unintended and disturbing consequence of nontreatment: some anomalous infants survive anyway and suffer even worse handicaps because early aggressive care was withheld.
The dispute also involves lawyers and ethicists. The author presents several major schools of thought, with clear explanations of relevant legal and ethical principles.
